Lazarus HM - Search Results

1

Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.

Saarinen UM, Strandjord SE, Warkentin PI, Cheung NK, Lazarus HM, Coccia PF. Saarinen UM, et al. Among authors: lazarus hm. Transplantation. 1987 Oct;44(4):540-6. doi: 10.1097/00007890-198710000-00017. Transplantation. 1987. PMID: 3313843

2

In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.

Stein J, Strandjord S, Saarinen U, Warkentin P, Gerson S, Lazarus H, Von Hoff D, Coccia P, Cheung NK. Stein J, et al. Prog Clin Biol Res. 1988;271:237-48. Prog Clin Biol Res. 1988. PMID: 3043451 No abstract available.

3

Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.

Herzig RH, Coccia PF, Lazarus HM, Strandjord SE, Graham-Pole J, Cheung NK, Gordon EM, Gross S, Spitzer TR, Warkentin PI, et al. Herzig RH, et al. Among authors: lazarus hm. Semin Oncol. 1985 Jun;12(2 Suppl 3):184-6. Semin Oncol. 1985. PMID: 3892700 No abstract available.

4

Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.

Lazarus HM, Coccia PF, Herzig RH, Graham-Pole J, Gross S, Strandjord S, Gordon E, Cheung NK, Warkentin PI, Spitzer TR, et al. Lazarus HM, et al. Blood. 1984 Jul;64(1):215-20. Blood. 1984. PMID: 6375759 Free article.

5

Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).

Lazarus HM, Vogelsang GB, Rowe JM. Lazarus HM, et al. Bone Marrow Transplant. 1997 Mar;19(6):577-600. doi: 10.1038/sj.bmt.1700710. Bone Marrow Transplant. 1997. PMID: 9085738 Review.

6

Bone marrow transplantation with high-dose cytosine arabinoside.

Herzig RH, Lazarus HM, Graham-Pole J, Gross S, Coccia P, Gordon EM, Strandjord S, Phillips GL, Herzig GP. Herzig RH, et al. Among authors: lazarus hm. Med Pediatr Oncol. 1982;10 Suppl 1:235-8. doi: 10.1002/mpo.2950100724. Med Pediatr Oncol. 1982. PMID: 6761567

7

American Society for Blood and Marrow Transplantation guidelines for clinical centers.

Phillips G, Armitage J, Bearman S, Bitran J, Fay J, Forman S, Hurd D, Lazarus H, Warkentin P, Wolf J, et al. Phillips G, et al. Biol Blood Marrow Transplant. 1995 Nov;1(1):54-5. Biol Blood Marrow Transplant. 1995. PMID: 9118291 No abstract available.

8

High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.

Graham-Pole J, Lazarus HM, Herzig RH, Gross S, Coccia P, Weiner R, Strandjord S. Graham-Pole J, et al. Among authors: lazarus hm. Am J Pediatr Hematol Oncol. 1984 Spring;6(1):17-26. Am J Pediatr Hematol Oncol. 1984. PMID: 6370012

9

Severe acute graft-versus-host disease of conjunctivae after allogeneic blood progenitor cell infusion.

Spiro TP, O'Day DG, Bardenstein D, Cooper BW, Lazarus HM. Spiro TP, et al. Among authors: lazarus hm. Bone Marrow Transplant. 1996 Jun;17(6):1179-80. Bone Marrow Transplant. 1996. PMID: 8807133

10

Blood cell and bone marrow transplants.

Lazarus HM, Gale RP. Lazarus HM, et al. Bone Marrow Transplant. 1996 Nov;18(5):839-41. Bone Marrow Transplant. 1996. PMID: 8932834 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

776 results

Search Page

Filters